A microbiome assessment of medical marijuana.


Thompson GR 3rd, Tuscano JM, Dennis M, Singapuri A, Libertini S, Gaudino R, Torres A, Delisle JM, Gillece JD, Schupp JM, Engelthaler DM.
Clin Microbiol Infect. 2017 Apr;23(4):269-270.


Letter to the editor.

To reduce the risk of infection in highly immunocompromisedpatients, prophylactic antibacterial, antifungal and antiviral agentsare frequently prescribed and patients are routinely advised toreduce their risk of exposure byavoiding soil, plants and cutflowersdue to the presence ofAspergillusand other moulds andNocardiaspp.[1,2]. Other recommendations to limit exposures include theavoidance of water-retaining materials given their associationwithPseudomonas aeruginosa, raw vegetable sprouts (Escherichiacoli), undercooked eggs (Salmonella enteritidis), fresh salsa, andberries (Cyclosporaetc.) among others[1]. These recommendationsdo not comment on the infectious risks of medical marijuanadasubstance now legal in 11 countriesdand used by ~13% of the USpopulation yearly